C07D 211/14
With hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Official title: with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
C07D211/14 (With hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom) appears on 685 US grants and 579 published applications in this corpus.
Search patents in C07D- Granted patents
- 685
- Published applications
- 579
- Assignees
- 398
- Inventors
- 2,290
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 21 | 0 |
| 1978 | 14 | 0 |
| 1979 | 4 | 0 |
| 1980 | 8 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 7 | 0 |
| 1984 | 3 | 0 |
| 1985 | 10 | 0 |
| 1986 | 7 | 0 |
| 1987 | 7 | 0 |
| 1988 | 3 | 0 |
| 1989 | 7 | 0 |
| 1990 | 11 | 0 |
| 1991 | 10 | 0 |
| 1992 | 15 | 0 |
| 1993 | 14 | 0 |
| 1994 | 12 | 0 |
| 1995 | 8 | 0 |
| 1996 | 6 | 0 |
| 1997 | 37 | 0 |
| 1998 | 11 | 0 |
| 1999 | 12 | 0 |
| 2000 | 16 | 0 |
| 2001 | 22 | 2 |
| 2002 | 19 | 16 |
| 2003 | 17 | 23 |
| 2004 | 9 | 37 |
| 2005 | 15 | 32 |
| 2006 | 13 | 25 |
| 2007 | 10 | 19 |
| 2008 | 13 | 16 |
| 2009 | 21 | 20 |
| 2010 | 16 | 34 |
| 2011 | 13 | 18 |
| 2012 | 18 | 28 |
| 2013 | 23 | 22 |
| 2014 | 24 | 21 |
| 2015 | 22 | 36 |
| 2016 | 25 | 28 |
| 2017 | 20 | 23 |
| 2018 | 21 | 16 |
| 2019 | 17 | 16 |
| 2020 | 10 | 18 |
| 2021 | 13 | 24 |
| 2022 | 11 | 22 |
| 2023 | 9 | 21 |
| 2024 | 14 | 17 |
| 2025 | 13 | 35 |
| 2026 | 11 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Substituted diaryl compound as well as preparation method and application thereof29 Sep 2026US 12,747,209 B2Shandong First Medical. Univ & Shandong Academy of Medical Sciences
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- TRPML modulators4 Aug 2026US 12,698,266 B2Casma Therapeutics, Inc.
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Erap1 modulating compounds16 Jul 2026US 2026/0199455 A1Grey Wolf Therapeutics Limited
- Ionizable lipids and compositions and uses thereof2 Jul 2026US 2026/0184671 A1Massachusetts Institute of Technology
- Use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives18 Jun 2026US 2026/0166022 A1Seyltx, Inc.
- Tertiary amide aldonamide based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation28 May 2026US 2026/0146239 A1PanTHERA CryoSolutions Inc.
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Intermediates of peripherally selective N-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists116US 5,159,081 AEli Lilly and Company · 1992
- Peripherally selective piperidine opioid antagonists86US 5,270,328 AEli Lilly and Company · 1993
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009
- Cyclohexane derivatives76US 4,510,069 AMerck Patent GmbH · 1985